Verona Pharma Competitors and Similar CompaniesClear all
Verona Pharma's competitors and similar companies include ReCode Therapeutics, Servier, Aurobindo Pharma and Glenmark Pharmaceuticals.
 Verona Pharma Verona Pharma is a biotechnology company dedicated to discovering new drugs for the treatment of chronic respiratory diseases. |  ReCode Therapeutics ReCode Therapeutics is a company developing non-viral nanoparticles for delivery of diverse RNA- and protein-based therapeutics to targeted tissues, and tRNA NanoCorrectors. |  Aurobindo Pharma Aurobindo Pharma, a pharmaceutical company, manufactures and sells generic medicines to public and private health sectors in South Africa. |  Glenmark Pharmaceuticals Glenmark Pharmaceuticals is a pharmaceutical company that develops and markets branded and generic formulations. | ||
Founding Date | Founding Date N/A | Founding Date 2015 | Founding Date 1954 | Founding Date 1986 | Founding Date 1977 |
Type | Type Public | Type Private | Type Private | Type Public | Type Public |
Tags | |||||
Locations | Locations London, GB HQ Cardiff, GB Raleigh, US | Locations Menlo Park, US HQ | Locations Suresnes, FR HQ Sidi M'hamed, DZ Yerevan, AM Hawthorn, AU Melbourne, AU Vienna, AT Baku, AZ see more | Locations Hyderabad, IN HQ Hyderabad, IN South Brunswick Township, US | Locations Mumbai, IN HQ Mumbai, IN |
Employees | Employees 79 | Employees 1062% decrease | Employees 12,9983% increase | Employees 26,015 | Employees 14,989 |
Financial | |||||
Revenue (est.) | Revenue (est.) $42.3m (FY, 2024) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) ₹333.8b (FY, 2026) | Revenue (est.) ₹131.5b (FY, 2025) |
Cost of goods | Cost of goods $1.4m (FY, 2024) | Cost of goods N/A | Cost of goods N/A | Cost of goods ₹134.9b (FY, 2026) | Cost of goods ₹46.7b (FY, 2025) |
Gross profit | Gross profit $40.9m (FY, 2024) | Gross profit N/A | Gross profit N/A | Gross profit ₹206.6b (FY, 2026) | Gross profit ₹87b (FY, 2025) |
Net income | Net income ($173.2m) (FY, 2024) | Net income N/A | Net income N/A | Net income ₹35b (FY, 2026) | Net income ₹10.5b (FY, 2025) |
Funding | |||||
Total funding raised | Total funding raised $ 11.5m | Total funding raised $ 82m | Total funding raised N/A | Total funding raised N/A | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
ReCode Therapeutics
HQ
Menlo Park, US
Employees
106↓ 2% decrease
ReCode Therapeutics is a company developing non-viral nanoparticles for delivery of diverse RNA- and protein-based therapeutics to targeted tissues, and tRNA NanoCorrectors.
View company
Servier
HQ
Suresnes, FR
Employees
12,998↑ 3% increase
Servier, founded in 1954, is the first independent pharmaceutical group.
View companyAurobindo Pharma
HQ
Hyderabad, IN
Employees
26,015
Aurobindo Pharma, a pharmaceutical company, manufactures and sells generic medicines to public and private health sectors in South Africa.
View companyGlenmark Pharmaceuticals
HQ
Mumbai, IN
Employees
14,989
Glenmark Pharmaceuticals is a pharmaceutical company that develops and markets branded and generic formulations.
View company